Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Kwok-Yung Yuen and Zhiwei Chen.
Connection Strength

2.410
  1. Natural Transmission of Bat-like Severe Acute Respiratory Syndrome Coronavirus 2 Without Proline-Arginine-Arginine-Alanine Variants in Coronavirus Disease 2019 Patients. Clin Infect Dis. 2021 07 15; 73(2):e437-e444.
    View in: PubMed
    Score: 0.239
  2. Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies. Cell Host Microbe. 2021 04 14; 29(4):551-563.e5.
    View in: PubMed
    Score: 0.233
  3. Host and viral determinants for efficient SARS-CoV-2 infection of the human lung. Nat Commun. 2021 01 08; 12(1):134.
    View in: PubMed
    Score: 0.231
  4. High neutralizing antibody titer in intensive care unit patients with COVID-19. Emerg Microbes Infect. 2020 Dec; 9(1):1664-1670.
    View in: PubMed
    Score: 0.229
  5. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target. Sci Adv. 2020 08; 6(35):eaba7910.
    View in: PubMed
    Score: 0.225
  6. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses. Immunity. 2020 10 13; 53(4):864-877.e5.
    View in: PubMed
    Score: 0.224
  7. Vedolizumab-mediated integrin a4ß7 blockade does not control HIV-1SF162 rebound after combination antiretroviral therapy interruption in humanized mice. AIDS. 2019 03 15; 33(4):F1-F12.
    View in: PubMed
    Score: 0.203
  8. Gut-homing ?42PD1+Vd2 T cells promote innate mucosal damage via TLR4 during acute HIV type 1 infection. Nat Microbiol. 2017 Oct; 2(10):1389-1402.
    View in: PubMed
    Score: 0.182
  9. High prevalence of four novel astrovirus genotype species identified from rodents in China. J Gen Virol. 2017 May; 98(5):1004-1015.
    View in: PubMed
    Score: 0.179
  10. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J Virol. 2005 Mar; 79(5):2678-88.
    View in: PubMed
    Score: 0.077
  11. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. Chem Biol. 2004 Sep; 11(9):1293-9.
    View in: PubMed
    Score: 0.074
  12. A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters. Emerg Microbes Infect. 2021 Dec; 10(1):874-884.
    View in: PubMed
    Score: 0.061
  13. Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nat Commun. 2021 07 09; 12(1):4210.
    View in: PubMed
    Score: 0.060
  14. Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein. Nat Commun. 2021 05 13; 12(1):2790.
    View in: PubMed
    Score: 0.059
  15. Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction. Emerg Microbes Infect. 2020 Dec; 9(1):837-842.
    View in: PubMed
    Score: 0.057
  16. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020 08; 584(7821):450-456.
    View in: PubMed
    Score: 0.056
  17. Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J Med Virol. 2006 Jan; 78(1):1-8.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.